Thiogenesis Therapeutics, Corp.
TTIPF
$0.6468
$0.086815.50%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.10% | -67.17% | -1.18% | 9.68% | 65.39% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.28% | 336.16% | -44.01% | -18.79% | -14.24% |
| Change in Net Operating Assets | 4.33% | 291.75% | -735.48% | 102.45% | -207.65% |
| Cash from Operations | -50.30% | 37.15% | -51.96% | 72.79% | -189.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 3,527.14% | -- | -100.00% | -88.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 3,456.86% | -- | -100.00% | -88.68% |
| Foreign Exchange rate Adjustments | 76.70% | -402.94% | 288.89% | 87.23% | -195.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -171.74% | 64.60% | -49.18% | 64.86% | -145.48% |